Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Sales | 1,651 | 1,705 | 1,227 | 1,517 | 1,545 |
| Gross Profit | 1,651 | 1,705 | 1,227 | 1,517 | 1,545 |
| Operating Income | 1,651 | 1,705 | 1,227 | 1,517 | 1,545 |
| Pre-tax Income | 1,651 | 1,705 | 1,227 | 1,517 | 1,545 |
| Net Income Continuous | -3,971 | -4,031 | -3,919 | -4,296 | -3,620 |
| Net Income | $-3,971 | $-4,031 | $-3,919 | $-4,296 | $-3,620 |
| EPS Basic Total Ops | -3.96 | -3.96 | -4.32 | -5.76 | -5.04 |
| EPS Basic Continuous Ops | -3.89 | -3.96 | -4.22 | -5.64 | -5.05 |
| EPS Diluted Total Ops | -3.96 | -3.96 | -4.32 | -5.76 | -5.04 |
| EPS Diluted Continuous Ops | -3.89 | -3.96 | -4.22 | -5.64 | -5.05 |
| EBITDA(a) | $1,651 | $1,705 | $1,227 | $1,517 | $1,545 |